The global Global Pharmaceutical Chemicals Market is expected to grow at 7.2% CAGR from 2025 to 2032. The global Global Pharmaceutical Chemicals Market Report offers an in-depth analysis of the ...

In a report released yesterday, Umer Raffat from Evercore ISI maintained a Buy rating on Merck & Company (MRK – Research Report). The company’s shares closed yesterday at $89.67. Leverage the ...

Bernstein analyst Courtney Breen maintained a Hold rating on Merck & Company (MRK – Research Report) yesterday and set a price target of $110.00. The company’s shares closed yesterday at $89.67.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The global Global Pharmaceutical Chemicals Market is expected to grow at 7.2% CAGR from 2025 to 2032. The global Global Pharmaceutical Chemicals Market Report offers an in-depth analysis of the Market ...

"Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut ...

SEC Filings provided by EDGAR Online, Inc.

During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...

In October, Merck took up an option on the personalised RNA-based cancer vaccine with an upfront payment of $250 million as part of a collaboration first agreed in 2016 and expanded in 2018.

BEIRUT — A delegation from the global chemical weapons watchdog arrived in Damascus Saturday to meet with Syria’s new leaders for the first time since the fall of former President Bashar Assad.